207 related articles for article (PubMed ID: 24433758)
1. Automatic cervical cell segmentation and classification in Pap smears.
Chankong T; Theera-Umpon N; Auephanwiriyakul S
Comput Methods Programs Biomed; 2014 Feb; 113(2):539-56. PubMed ID: 24433758
[TBL] [Abstract][Full Text] [Related]
2. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
William W; Ware A; Basaza-Ejiri AH; Obungoloch J
Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
[TBL] [Abstract][Full Text] [Related]
3. Automated classification of Pap smear images to detect cervical dysplasia.
Bora K; Chowdhury M; Mahanta LB; Kundu MK; Das AK
Comput Methods Programs Biomed; 2017 Jan; 138():31-47. PubMed ID: 27886713
[TBL] [Abstract][Full Text] [Related]
4. Deep Convolution Neural Network for Malignancy Detection and Classification in Microscopic Uterine Cervix Cell Images.
P B S; Faruqi F; K S H; Kudva R
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3447-3456. PubMed ID: 31759371
[TBL] [Abstract][Full Text] [Related]
5. Debris removal in Pap-smear images.
Malm P; Balakrishnan BN; Sujathan VK; Kumar R; Bengtsson E
Comput Methods Programs Biomed; 2013 Jul; 111(1):128-38. PubMed ID: 23582663
[TBL] [Abstract][Full Text] [Related]
6. A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
William W; Ware A; Basaza-Ejiri AH; Obungoloch J
Biomed Eng Online; 2019 Feb; 18(1):16. PubMed ID: 30755214
[TBL] [Abstract][Full Text] [Related]
7. An automated cervical pre-cancerous diagnostic system.
Mat-Isa NA; Mashor MY; Othman NH
Artif Intell Med; 2008 Jan; 42(1):1-11. PubMed ID: 17996432
[TBL] [Abstract][Full Text] [Related]
8. DeepPap: Deep Convolutional Networks for Cervical Cell Classification.
Zhang L; Le Lu ; Nogues I; Summers RM; Liu S; Yao J
IEEE J Biomed Health Inform; 2017 Nov; 21(6):1633-1643. PubMed ID: 28541229
[TBL] [Abstract][Full Text] [Related]
9. Nominated texture based cervical cancer classification.
Mariarputham EJ; Stephen A
Comput Math Methods Med; 2015; 2015():586928. PubMed ID: 25649913
[TBL] [Abstract][Full Text] [Related]
10. Semi-automatic segmentation and classification of Pap smear cells.
Chen YF; Huang PC; Lin KC; Lin HH; Wang LE; Cheng CC; Chen TP; Chan YK; Chiang JY
IEEE J Biomed Health Inform; 2014 Jan; 18(1):94-108. PubMed ID: 24403407
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Alanen KW; Elit LM; Molinaro PA; McLachlin CM
Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
13. Nucleus segmentation and classification using residual SE-UNet and feature concatenation approach incervical cytopathology cell images.
Chowdary GJ; G S; M P; Yogarajah P
Technol Cancer Res Treat; 2023; 22():15330338221134833. PubMed ID: 36744768
[No Abstract] [Full Text] [Related]
14. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
15. A Novel Approach of Mathematical Theory of Shape and Neuro-Fuzzy Based Diagnostic Analysis of Cervical Cancer.
Kar S; Majumder DD
Pathol Oncol Res; 2019 Apr; 25(2):777-790. PubMed ID: 30729412
[TBL] [Abstract][Full Text] [Related]
16. [Cytological classification of precancer and cancer of the cervix uteri].
Agamova KA; Nikitina NI; Gosh TE; Tikhomirova EE; Gladunova ZD
Vopr Onkol; 1987; 33(5):54-9. PubMed ID: 3590668
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of abnormal pap smear at Thammasat University Hospital.
Kanjanavirojkul N; Muanglek R; Yanagihara L
J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S79-82. PubMed ID: 23964448
[TBL] [Abstract][Full Text] [Related]
20. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
